SCHEMBL21696261

SCHEMBL21696261

C1COCCN(C2CNC2)C1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.37
L3MBTL3 Q96JM7 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ALDH1A1 P00352 2/20 0.33
CYP2A13 Q16696 1/20 0.33
HPGD P15428 1/20 0.33
DPP4 P27487 1/20 0.33
PDK1 Q15118 1/20 0.31
PDK2 Q15119 1/20 0.31
PDK3 Q15120 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MAPK8 P45983 1/20 0.30
MAPK9 P45984 1/20 0.30
MAPK10 P53779 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL91524 0.91 SMN1; SMN2 (0.42) HTR6SMN1; SMN2L3MBTL3L3MBTL1ALDH1A1
Hydrochloric Acid SCHEMBL5331592 0.89 SMN1; SMN2 (0.41) HTR6SMN1; SMN2L3MBTL3L3MBTL1ALDH1A1
Hydrochloric Acid SCHEMBL1368786 0.89 SMN1; SMN2 (0.41) HTR6SMN1; SMN2L3MBTL3L3MBTL1ALDH1A1
SCHEMBL22527614 0.84 HTR6 (0.53) HTR6SMN1; SMN2L3MBTL3L3MBTL1ALDH1A1
SCHEMBL31209302 0.84 HTR6 (0.53) HTR6SMN1; SMN2L3MBTL3L3MBTL1ALDH1A1
SCHEMBL22527667 0.83 HTR6 (0.56) HTR6SMN1; SMN2L3MBTL3L3MBTL1ALDH1A1
SCHEMBL16837198 0.83 SMN1; SMN2 (0.41) HTR6SMN1; SMN2L3MBTL3L3MBTL1ALDH1A1
SCHEMBL15600760 0.79 L3MBTL3 (0.41) HTR6SMN1; SMN2L3MBTL3L3MBTL1ALDH1A1
SCHEMBL3056808 0.78
SCHEMBL3810047 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2800745-B1 PYRROLO CARBOXAMIDES AS MODULATORS OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORY, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASES PHENEX PHARMACEUTICALS AG (DE) 2020-02-12 EP disclosed